David P Southwell - Net Worth and Insider Trading
David P Southwell Net Worth
The estimated net worth of David P Southwell is at least $3 Million dollars as of 2024-11-13. David P Southwell is the Director of Rocket Pharmaceuticals Inc and owns about 114,784 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $2 Million. David P Southwell is the CEO of TScan Therapeutics Inc and owns about 171,569 shares of TScan Therapeutics Inc (TCRX) stock worth over $931,620. David P Southwell is also the Director of PTC Therapeutics Inc and owns about 10,500 shares of PTC Therapeutics Inc (PTCT) stock worth over $468,510. Besides these, David P Southwell also holds First Eagle Alternative Capital BDC Inc (FCRD) . Details can be seen in David P Southwell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David P Southwell has not made any transactions after 2024-04-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David P Southwell
David P Southwell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David P Southwell owns 5 companies in total, including PTC Therapeutics Inc (PTCT) , Rocket Pharmaceuticals Inc (RCKT) , and Spero Therapeutics Inc (SPRO) among others .
Click here to see the complete history of David P Southwell’s form 4 insider trades.
Insider Ownership Summary of David P Southwell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PTCT | PTC Therapeutics Inc | 2023-04-17 | director |
RCKT | Rocket Pharmaceuticals Inc | 2024-04-15 | director & See Remarks |
SPRO | Spero Therapeutics Inc | 2018-02-01 | director |
2010-12-06 | director | ||
2022-05-18 | director & Chief Executive Officer |
David P Southwell Latest Holdings Summary
David P Southwell currently owns a total of 4 stocks. Among these stocks, David P Southwell owns 114,784 shares of Rocket Pharmaceuticals Inc (RCKT) as of April 15, 2024, with a value of $2 Million and a weighting of 53.88%. David P Southwell owns 171,569 shares of TScan Therapeutics Inc (TCRX) as of May 18, 2022, with a value of $931,620 and a weighting of 27.28%. David P Southwell also owns 10,500 shares of PTC Therapeutics Inc (PTCT) as of April 17, 2023, with a value of $468,510 and a weighting of 13.72%. The other 1 stocks First Eagle Alternative Capital BDC Inc (FCRD) have a combined weighting of 5.12% among all his current holdings.
Latest Holdings of David P Southwell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RCKT | Rocket Pharmaceuticals Inc | 2024-04-15 | 114,784 | 16.03 | 1,839,988 |
TCRX | TScan Therapeutics Inc | 2022-05-18 | 171,569 | 5.43 | 931,620 |
PTCT | PTC Therapeutics Inc | 2023-04-17 | 10,500 | 44.62 | 468,510 |
FCRD | First Eagle Alternative Capital BDC Inc | 2010-12-06 | 38,500 | 4.54 | 174,790 |
Holding Weightings of David P Southwell
David P Southwell Form 4 Trading Tracker
According to the SEC Form 4 filings, David P Southwell has made a total of 1 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the sale of 80,000 shares on April 15, 2024, which brought David P Southwell around $2 Million.
According to the SEC Form 4 filings, David P Southwell has made a total of 2 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 25,000 shares on May 18, 2022, which cost David P Southwell around $89,750.
According to the SEC Form 4 filings, David P Southwell has made a total of 3 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 11,429 shares on April 17, 2023, which brought David P Southwell around $583,222.
More details on David P Southwell's insider transactions can be found in the Insider Trading History of David P Southwell table.Insider Trading History of David P Southwell
- 1
David P Southwell Trading Performance
GuruFocus tracks the stock performance after each of David P Southwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Southwell is -2.03%. GuruFocus also compares David P Southwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Southwell within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David P Southwell's insider trading performs compared to the benchmark.
Performance of David P Southwell
David P Southwell Ownership Network
Ownership Network List of David P Southwell
Ownership Network Relation of David P Southwell
David P Southwell Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
David P Southwell is the director of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, David P Southwell made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,039 shares made by Eric Pauwels , a net sale of 22,455 shares made by Matthew B. Klein , and a net sale of 2,701 shares made by Lee Scott Golden .
In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,302 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 106,602 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
David P Southwell Mailing Address
Above is the net worth, insider trading, and ownership report for David P Southwell. You might contact David P Southwell via mailing address: C/o Inotek Pharmaceuticals Corporation, 91 Hartwell Avenue, Lexington Ma 02421.